Key Takeaways:
Morgan Stanley cut its price target for Brilliance China Automotive Holdings (01114.HK) by 15 percent to HK$2.90, citing greater-than-expected operational pressure on its core joint venture with BMW.
The bank maintained its "In-line" rating on the stock. The new target price implies a modest upside from the current trading level, reflecting the bank's view that some pressures are already priced in.
The revision follows a significant sales decline at the BMW Brilliance Automotive (BBA) joint venture, which saw sales drop 10 percent in the first four months of 2026. This slowdown contributed to Brilliance China's 2025 net profit coming in 25 percent below Morgan Stanley's expectations. Consequently, the bank reduced its net profit forecasts for 2026 and 2027 by 7 percent and 8 percent, respectively.
The challenges for the BBA venture reflect intense competition in China's auto market, where foreign brands are losing ground to domestic manufacturers. Chinese automakers are rapidly expanding, particularly in the new-energy vehicle (NEV) segment, where they accounted for about 70 percent of global sales in 2025. This has reshaped the competitive landscape, pressuring established players like BMW and their local partners.
Despite the earnings forecast reduction, Morgan Stanley raised the target price-to-earnings multiple for the BBA joint venture to 4x from 3x. The bank's analysts believe the margin pressures have been partially reflected in the 2025 profit decline and are expected to ease.
The sales slowdown at the joint venture remains a key headwind for Brilliance China's stock. Investors will be closely watching the company's next earnings release to see if the trend persists or if stabilization measures are taking effect.
This article is for informational purposes only and does not constitute investment advice.
